News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Alnylam (ALNY) Stock Catapults as Genetic Disease Drug Meets All Phase III Goals     9/20/2017
Startup Whiz Kid Vivek Ramaswamy Does it Again, Launches Bay Area Firm to Revolutionize Clinical Trials     9/20/2017
Why Struggling MannKind (MNKD) is Struggling No More     9/20/2017
Tiny Massachusetts Biotech Corbus (CRBP) to Triple HQ Space to Accommodate Growth     9/20/2017
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva (TEVA)     9/20/2017
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma     9/20/2017
Eli Lilly (LLY) Heads to Finish Line with Breast Cancer Treatment Abemaciclib     9/20/2017
Boston's Juniper Pharma Suspends Program, Cuts 8% of R&D Jobs and CMO Steps Down     9/19/2017
Growing Catalent (CTLT) Takes Out Cook Pharmica in $950 Million Deal     9/19/2017
How Gilead (GILD)'s $12 Billion Kite Pharma (KITE) Deal Has Already Paid Off for Investors     9/19/2017
Former GlaxoSmithKline (GSK) CEO and R&D Boss Secure New Gigs at Biotech VC Firms     9/19/2017
Booming Rho to Go on 40-Person+ Hiring Binge     9/19/2017
Biotech Startup Bonanza Continues as Disarm Therapeutics Emerges With $30 Million     9/19/2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials     9/19/2017
Johnson & Johnson (JNJ)-Backed Science Project to Create Champions of Science, Challenge Stereotypes     9/19/2017

News from Around the Web
3 Reasons Booming Exelixis (EXEL) Still Doesn't Meet Warren Buffet's Criteria     9/20/2017
Alcobra (ADHD) Is A Net-Net That Could Sell Itself     9/20/2017
No More 'Bad Fat'? A Potential Weight-Loss Treatment Could Make Fat Burn Itself, Washington University in St. Louis Study Reveals     9/20/2017
People With Schizophrenia Have Threefold Risk Of Dying, Canadian Medical Association Journal Reveals     9/20/2017
Acadia (ACAD): Where's The Upside From Current Levels?     9/20/2017
New Assay Leads To Step Toward Gene Therapy For Deaf Patients, Oregon State University Study     9/20/2017
Bayer (BAY) Stops Essure Implant Sales Outside of the U.S.     9/20/2017
Fluorescence Microscopy On A Chip: No Lenses Required, American Institute of Physics Reveals     9/20/2017
Nanocapsules Enable Cell-Inspired Metabolic Reactions, University of Basel Study     9/20/2017
New Bionic-Eye Brain Implants Could Help More Blind People Than A Device Already On The Market     9/20/2017
3 Of The Most Innovation-Forward Biotechs Right Now     9/19/2017
Why Bayer (BAY)'s $66 Billion Takeover Of Monsanto (MON) Probably Won't Happen Until 2018     9/19/2017
OptiNose Files for $100 Million IPO     9/19/2017
Will You Lose Weight? Take A Look At Your Poop, University of Copenhagen Study Reveals     9/19/2017
Is This The Best Oncology Play In The Market?     9/19/2017

Press Releases
Lexicon Pharma (LXRX) Release: European Commission (EC) Approves XERMELO (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy     9/20/2017
Shire (SHPG), Shionogi's Adult ADHD Drug Hits Phase III Goals     9/20/2017
Lightstone Ventures Closes New Life Sciences Fund At $250 Million     9/20/2017
Aerie (AERI) Poaches Another Exec From Novartis AG (NVS)' Tormented Alcon (ACL) Biz     9/20/2017
GlaxoSmithKline (GSK) And Innoviva Inc. (THRX) Report Positive Headline Results From IMPACT Study Showing Single Inhaler Triple Therapy Trelegy Ellipta Reduced COPD Exacerbations     9/20/2017
Alnylam (ALNY) And Sanofi (SNY) Report Positive Topline Results From APOLLO Phase III Study Of Patisiran In Hereditary ATTR (Hattr) Amyloidosis Patients With Polyneuropathy     9/20/2017
Supernus (SUPN) Plummets On Drug Study Change     9/20/2017
Sun Pharma (SUNPHARMA.NS) Odomzo (Sonidegib) New Label Approval Shows Sustained Duration Of Response Of 26 Months In Treatment Of Locally Advanced Basal Cell Carcinoma     9/20/2017
BioCardia Announces Publication Of 12-Month Results From Phase II TRIDENT Clinical Trial That Shows Positive Safety Profile For Allogeneic Bone Marrow Stem Cells Delivered With Helix Transendocardial Delivery System     9/20/2017
MYOS RENS Technology Appoints Joseph Mannello As Permanent Chief Executive Officer     9/20/2017
Arvinas Appoints Dr. John Houston As President And Chief Executive Officer     9/20/2017
Novartis AG (NVS) Drug Rydapt (Midostaurin) Receives EU Approval For Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Advanced Systemic Mastocytosis (SM)     9/20/2017
Lipocine (LPCN) Announces FDA Advisory Committee Meeting For TLANDO     9/20/2017
Sancilio Pharmaceuticals Company, Inc. Receives Rare Pediatric Disease Designation From The FDA For Altemia A Treatment Of Sickle Cell Disease (SCD) In Children     9/20/2017
Elite Pharma (ELI) Files ANDA For Oxycodone Hydrochloride Extended Release     9/20/2017
Gemphire Announces Plans To Advance Gemcabene Into Phase III Clinical Development     9/20/2017
FDA Indicates That Jaguar’s Canalevia Drug Product Candidate Qualifies As "Minor Use" For Exercise-Induced Diarrhea (EID) In Dogs, Rendering Canalevia Eligible For Conditional Approval For This Indication     9/20/2017
Altimmune Announces its Phase II Flu Vaccine Trial With NasoVAX Open For Enrollment     9/20/2017
Argenx Reaches 50% Enrollment In Phase II Clinical Trial Of ARGX-113 In Immune Thrombocytopenia     9/20/2017
International Stem Cell Corporation To Move Forward With Traumatic Brain Injury Phase II Clinical Trial     9/20/2017
Edinburgh Molecular Imaging Commences Phase II European Cancer Trial     9/20/2017
Cavion Announces First Patient Enrolled In Its Multi-Center Phase II Clinical Trial In Essential Tremor     9/20/2017
The Parker Institute For Cancer Immunotherapy And The Cancer Research Institute Announce First Patients Treated In Pancreatic Cancer Clinical Trial Combining Immunotherapy And Chemotherapy     9/20/2017
Emerald Health Pharmaceuticals’ Scientific Team Leads Cannabinoid Research Showing Potential To Impact Neurodegenerative Diseases     9/20/2017
Protagonist (PTGX) Announces Preliminary Phase I Study Results With Novel Hepcidin Mimetic, PTG-300     9/20/2017
PharmaMar Starts Clinical Studies With A New Compound –PM14- In Patients With Solid Tumors     9/20/2017
KemPharm (KMPH) Files IND For KP484 For The Treatment Of ADHD, An Investigational Prodrug Of Methylphenidate     9/20/2017
Poxel (POXEL.PA) Announces PXL770 Advances Into A Phase Ib Multiple Ascending Dose Trial     9/20/2017
Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery Of THCA Cannabinoid’s Neuroprotective Treatment Potential     9/20/2017
Propeller Health Presents Data On Asthma And COPD At The European Respiratory Society International Congress     9/20/2017
Selexis SA, Spinomix And The University Of Lausanne Publish Novel, High-Throughput Technology Process For Isolation Of High Secretion CHO Cell Clones     9/20/2017
Alzheimer’s Research UK Blood Magnesium Levels Linked With Dementia Risk     9/20/2017
Acer Therapeutics And Opexa Therapeutics (OPXA) Close Merger And Financing     9/20/2017
ApconiX Release: New Drug Discovery Alliance To Tackle High Rate Of Failure In Drug Development     9/20/2017
SGI-DNA And BioCat GmbH Announce Distribution Partnership For Vmax Express Protein Expression Platform     9/20/2017
Cellular Dynamics Signs Agreement With Nanion To Enhance Mutual Offerings For Researchers     9/20/2017
Recipharm AB Signs Long-Term Manufacturing Agreement With Major New Customer And Acquires Facility In Spain     9/20/2017
XBiotech (XBIT) Announces Agreement With Cedars-Sinai Medical Center To Evaluate Mabp1 In Combination With Onivyde? And 5-Fluorouracil/Folinic Acid For The Treatment Of Pancreatic Cancer     9/20/2017
Spark Therapeutics (ONCE) Enters Into Licensing Agreement With Genethon     9/20/2017
Telix Pharma And Cellsight Technologies Conclude Collaboration And License Agreement For VisAcT ImmunoPET Technology     9/20/2017
Emerald Health Therapeutics Expands Its Cannabis Supply With Purchase From Supreme Pharmaceuticals     9/20/2017
Cerveau Technologies Announces Collaboration With Banner Health     9/20/2017
GlaxoSmithKline (GSK), AstraZeneca PLC (AZN) And Labcyte Inc. Form Alliance To Develop Acoustic Mass Spectrometry - A Novel Sample Handling Technology For MS-Based Drug Discovery     9/20/2017
AVEO Oncology (AVEO) And EUSA Pharma Announce Tinivo Combination Study Opt-In     9/20/2017
Eagle Pharma (EGRX) Licenses Japanese Rights For Bendamustine Hydrochloride Ready-To-Dilute And Rapid Infusion Injection Products To SymBio Pharma     9/20/2017
StemCell Technologies Inc. Signs Exclusive License With Propagenix To Commercialize Epix, An Innovation Empowering Epithelial Cell Biology And Cell Therapy     9/20/2017
Synpromics Announces Gene Therapy Research Partnership With Solid Biosciences     9/20/2017
Alcresta Receives New Innovative Technology Contract From Vizient, Inc. For Relizorb (Immobilized LIPASE) Cartridge     9/20/2017
Absorption Systems Embarks On Research Collaboration With The FDA     9/20/2017
Glythera And IONTAS Enter Into License Agreement For The Development Of Multiple Antibodies For Next-Generation Antibody Drug Conjugates     9/20/2017
ÉLÉPHANT VERT And Marrone Bio Innovations, Inc Sign Distribution Agreement In North Africa     9/20/2017
Soligenix (SNGX) Announces $1.5 Million NIDCR SBIR Grant Award Supporting The Pivotal Phase III Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer     9/20/2017
BioSensics Has Received Over $2.5 Million In Grant Funding From The NIH To Develop A Novel Telecare Solution For Huntington’s Disease     9/20/2017
Arbor Pharma Launches New Nymalize (Nimodipine) Oral Solution 10 Ml (30 Mg) Unit Dose For The Treatment Of Subarachnoid Hemorrhage     9/20/2017
Pulmatrix (PULM) Receives Key Patents On Its Inhaled Drug Delivery Technology And Its COPD Drug     9/20/2017
AOBiome Expands Intellectual Property Estate, Announces Issuance Of U.S. Patent For Ammonia Oxidizing Bacteria (AOB) For The Treatment Of Acne     9/20/2017
DelMar Pharma Announces Issuance Of New Patent On First-In-Class DNA-Targeting Agent, VAL-083     9/20/2017
Pfizer (PFE) Announces Outcome Of FDA Advisory Committee Meeting For SUTENT In Patients At High Risk Of Recurrent Renal Cell Carcinoma After Surgery     9/20/2017
PureTech Notes U.S. Patent Issuance Broadly Covering Methods Of Assessing Mental And Physical Condition From Human Speech     9/20/2017
SpinalCyte, LLC Announces New Australian Patent     9/20/2017
Merus (MRUS)’ Intellectual Property Portfolio Expands With Two New Patents For Its Biclonics Technology     9/20/2017
XW Laboratories Inc. Secures Over $17M Series B Financing Led By Elements Capital And WI Harper     9/20/2017
Cannabis Agricultural Biotech Company Front Range Biosciences Raises $3 Million in Bridge Round Funding     9/20/2017
Edesa Biotech Completes Financing To Develop Novel Dermatology And Anorectal Treatments     9/20/2017
NW Bio (NWBO) Announces Registered Direct Offering Of $1.75 Million     9/20/2017
Iovance Biotherapeutics Announces Public Offering Of Common Stock     9/20/2017
Nabriva (NBRV) Announces Pricing Of Public Offering Of Ordinary Shares Of Approximately $80 Million     9/20/2017
Marinus Pharma (MRNS) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriter’s Option To Purchase Additional Shares     9/20/2017
Paratek (PRTK) To Host Investor Day On October 17, 2017     9/20/2017
Krystal Biotech Announces Pricing Of Upsized Initial Public Offering     9/20/2017
Aclaris (ACRS) To Host R&D And Investor Event On October 4, 2017 In New York     9/20/2017
Capital Cell, Europe’s First Dedicated Life Sciences Crowdfunding Platform, Opens To UK Investors     9/20/2017
Körber Plans Takeover Of Systec & Services GmbH     9/20/2017
F-Prime Capital Announces Joshua Grass As New Entrepreneur-In-Residence     9/20/2017
Celcuity Announces Pricing Of Initial Public Offering     9/20/2017
Crohn's & Colitis Foundation Partners With Oxford University Press To Publish Inflammatory Bowel Diseases Journal     9/20/2017
PendoPharm Inc., A Division Of Pharmascience, Invests In Ontario Based Edesa Biotech And Licenses Three Novel Anorectal Treatments For Canada     9/20/2017
Acceleron Pharma Announces Proposed Public Offering Of Common Stock     9/20/2017
Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen     9/20/2017
NovaBay (NBY) Receives Notification Of Noncompliance With Additional NYSE American Continued Listing Standards     9/20/2017
Pfizer (PFE) Goes To Court To Allow Competition For Biologics And Expand Options For Patients     9/20/2017
AAHRPP Accredits Six More Research Organizations, Including First Department Of Defense Facility     9/20/2017
PSI Opens Office In Taiwan     9/20/2017
Oxitec To Build State-Of-The-Art Mosquito Egg Production Unit     9/20/2017
Enterome To Move Its Research Laboratories To Genopole, France's First Biocluster     9/20/2017
Benchling Announces Groundbreaking Workflow & Results Management Solution To Organize, Optimize, And Measure Biologics R&D     9/20/2017
DuPont (DD) Launches New DuPont Tyvek 40L In China With Plans For Global Availability In 2018     9/20/2017
MilliporeSigma Introduces Eshmuno P Anti-A And Anti-B Chromatography Resins For Enhancement Of Plasma-Derived Immunoglobulin     9/20/2017
Roivant Sciences Launches Datavant To Improve Clinical Trials With Artificial Intelligence     9/20/2017
Abbott (ABT) Hosts Conference Call For Third-Quarter Earnings     9/20/2017
Cesca Therapeutics Announces Fiscal Year 2017 Financial And Operating Results And Provides Corporate Update     9/20/2017
Merus (MRUS) Announces Second Quarter 2017 Financial Results And Highlights Recent Progress     9/20/2017
Mauna Kea Technologies Reports First Half 2017 Financial Results     9/20/2017
West Australian Neurologist Appointed President Of The World Federation Of Neurology     9/20/2017
DURECT (DRRX) Appoints Dr. Myriam Theeuwes As Senior Vice President, Clinical Development     9/20/2017
bluebird bio (BLUE) Appoints Mary Lynne Hedley, Ph.D. To Board Of Directors     9/20/2017
FibroGen (FGEN) Appoints Gerald Lema To Board Of Directors     9/20/2017
Intarcia Strengthens Board Of Directors For Next Stage Of Growth     9/20/2017
Mallinckrodt (MNK) Announces Election Of David Norton To Its Board Of Directors     9/20/2017
Sir Andrew Witty, Former CEO Of GlaxoSmithKline (GSK), Joins Synthego Advisory Board     9/20/2017
International Pharmaceutical And Nutrition Expert Dr. Jean Zetlaoui Joins VALBIOTIS’ Supervisory Board     9/20/2017
AVISTA Pharma Earns Carolina Star Safety Award     9/20/2017
Orphan Therapeutics, LLC Applauds Margaret Mcglynn For Trailblazer Lifetime Achievement Award     9/20/2017
SCIEX Researchers Receive Science And Technology Award At HUPO 2017 And Continues To Advance Proteomics Research     9/20/2017
Pulmatrix (PULM) Release: CEO Robert Clarke Discusses Positive Developments From Partnerships Obtained Within The Past Few Months     9/20/2017
Aurinia (AUPH) To Host R&D Day And Webcast On October 20th In New York, NY     9/20/2017
Auris Med (EARS) To Present At The LEERINK Partners Rare Disease Roundtable Series On September 27     9/20/2017
Syndax Announces Updated Presentation Time At The Cantor Fitzgerald Global Healthcare Conference     9/20/2017
Wilex AG (WL6.DE): Subsidiary Heidelberg Pharma To Present The Proprietary ATAC Technology Platform At The Annual World ADC Summit     9/20/2017
Data MATRIX Ltd. Release: SCDM Annual Conference In Orlando     9/20/2017
Stryker (SYK) Wins FDA Nod for 3D-Printed Tritanium C Anterior Cervical Cage     9/20/2017
FDA Green Lights Arkis Biosciences' CerebroFlo EVD Catheter With Endexo Technology     9/20/2017
Shockwave Medical Shows Off Disrupt BTK Lithoplasty System Study Results     9/20/2017
Johnson & Johnson (JNJ)'s DePuy Synthes Sells Prodisc Assets for an Undisclosed Sum     9/20/2017
Innovus Pharma’s Partner Luminarie Receives Approval For Zestra For Female Sexual Arousal Disorder As A Medical Device I From New Zealand’s Medicines And Medical Devices Safety Authority     9/20/2017
Mazor Robotics Announces CE Mark Approval For The Mazor X Surgical Assurance Platform     9/20/2017
Morehouse School of Medicine Release: Blood Tests Prove Accurate In Identifying Patients With Post-Concussion Syndrome     9/20/2017
Inspire Medical Systems' Inspire Therapy For Reducing Obstructive Sleep Apnea Demonstrates Long-Term Safety And Sustained Benefit Following 5 Years Of Treatment     9/20/2017
Cancer Genetics (CGIX) Announces 25th Contract Win To Provide Testing & Diagnostic Services For Combination Immuno-Oncology Clinical Trial     9/20/2017
DarioHealth Joins Philips-Backed Innovation Hub HighTechXL to Empower More Diabetes Patients To Analyze And Personalize Their Treatment     9/20/2017
Solace Power Signs Multi-Year Technology Licensing Agreement With Byrne     9/20/2017
Becton, Dickinson and Company (BDX) And Euroclone Announce Development And Global Distribution Agreement For Tests To Detect Emerging Sexually-Transmitted Pathogens     9/20/2017
Generex Biotechnology Corporation (GNBT) Announces New Clinical Trial Of Hema Diagnostic Systems’ Rapid 1-2-3 Tuberculosis Point-Of-Care Tests     9/20/2017
Natera Selected For Circulating Tumor DNA Study In Bladder Cancer     9/20/2017
Bio-Techne (TECH) Unveils A New Multi-Analyte Cartridge Format For The Ella Immunoassay Platform, Improving Sample Throughput     9/20/2017
VolitionRX Announces Its European Colorectal Cancer Strategy     9/20/2017
HTG Molecular Diagnostics (HTGM) Announces Issuance Of Two Method Patents Related To Its Technology     9/20/2017
I-MED Pharma Release: i-Pen Tear Osmolarity System Registered In Japan     9/20/2017
Aquagenx Launches New Quantitative Water Quality Test For Hydrogen Sulfide Bacteria     9/20/2017
Interpace Diagnostics Announces Receipt Of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements     9/20/2017
U.S. International Trade Commission Opens Investigation Into Fotona Dental Laser, Reports Millennium Dental Technologies     9/20/2017
N-Of-One To Incorporate New AMP Guidelines On Somatic Cancer Variants Into Its Best-In-Class Curation And Reporting For Patient-Specific Oncology Decision Support     9/20/2017
Analogic (ALOG) Announces Results For The Fourth Quarter And Fiscal Year Ended July 31, 2017 And Declares Quarterly Cash Dividend     9/20/2017
REVA Medical Announces Ray Larkin Jr. As Chairman Of The Board Of Directors     9/20/2017
Lombard Medical (LMT.L) Appoints Jonathan Hornsby As Vice President, Sales & Marketing     9/20/2017
HistoSonics Expands Leadership Team As It Accelerates Growth     9/20/2017
Augmenix To Unveil New Clinical Data On Its Innovative Absorbable Hydrogel Technology At The 59th Annual Meeting Of The American Society For Radiation Oncology     9/20/2017
TrovaGene (TROV) Strengthens Board Of Directors With Appointment Of Oncology Development Veteran Dr. Athena Countouriotis     9/20/2017

Career Tips
Hawaii's Boom in Biotech Jobs Lures Top Graduates     9/15/2017
Scientists: Is a Master’s Degree the New Bachelor’s Degree?     9/15/2017
New Career Path Emerges in Immuno-Biotechnology     9/15/2017
Scientists: Here Are The Pros And Cons Of Leaving Your Scientific Comfort Zone     9/12/2017
The End Of DACA And How It Affects Scientists     9/12/2017
5 Sure Ways Your Body Language Can Ruin A Job Search     9/12/2017
The Smartest Way To Answer A Recruiter's Email When You Don't Want The Job     9/12/2017
How Federal Budget Cuts Threaten San Diego's Life Science Jobs And Economy     9/12/2017
There’s Lots of Work at the Top 10 World’s Largest Pharmaceutical Companies     9/1/2017
What Does It Take to Get Hired by Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY)?     9/1/2017
8 Things You Didn't Know About South Carolina's Life Sciences Industry     8/31/2017
The Need for Speed in Today's Biotech Job Search and What This New Rush Means For You     8/17/2017
33 Company-Related Questions to Ask at a Large Pharmaceutical Job Interview     8/17/2017
CRO vs. Big Pharma: Which is the Better Place to Work?     8/7/2017
According to Real Scientists, This is How You Get a Job in Biopharma     8/4/2017

Other News Sources